Journal of Clinical Medicine · 2022 · 18 citations · 18 references
PharmacyInfectious DiseasesPharmacotherapyAntimicrobial PharmacotherapyAntimicrobial ResistanceAntimicrobial StewardshipAntibiotic ResistanceAntimicrobial Resistance PreventionAntimicrobial Stewardship ReviewHospital Antimicrobial StewardshipAntibiotic Stewardship In HospitalsAntimicrobial Stewardship EvaluationDrug-resistant PathogensEmpirical Therapy CoverageIntensive Care Unit Antimicrobial StewardshipIntensive Care Unit StewardshipStewardship ImplementationStewardship Intervention Implementation
Multidrug resistance has become a serious threat for health, particularly in hospital-acquired infections. To improve patients’ safety and outcomes while maintaining the efficacy of antimicrobials, complex interventions are needed involving infection control and appropriate pharmacological treatments in antibiotic stewardship programs. We conducted a multicenter pre-post study to assess the impact of a stewardship program in seven Italian intensive care units (ICUs). Each ICU was visited by a multidisciplinary team involving clinicians, microbiologists, pharmacologists, infectious disease specialists, and data scientists. Interventions were targeted according to the characteristics of each unit. The effect of the program was measured with a panel of indicators computed with data from the MargheritaTre electronic health record. The median duration of empirical therapy decreased from 5.6 to 4.6 days and the use of quinolones dropped from 15.3% to 6%, both p < 0.001. The proportion of multi-drug-resistant bacteria (MDR) in ICU-acquired infections fell from 57.7% to 48.8%. ICU mortality and length of stay remained unchanged, indicating that reducing antibiotic administration did not harm patients’ safety. This study shows that our stewardship program successfully improved the management of infections. This suggests that policy makers should tackle multidrug resistance with a multidisciplinary approach based on continuous monitoring and personalised interventions.
18
Anna-Pelagia Magiorakos, Arjun Srinivasan, Roberta B. Carey et al. · Clinical Microbiology and Infection · 2011 · 14K citations
Eili Klein, Maja Milkowska-Shibata, Katie K Tseng et al. · The Lancet Infectious Diseases · 2020 · 502 citations
Pharmacy, Pharmaceutical Policy, Antimicrobial Stewardship +14
Jan J. De Waele, Murat Akova, Massimo Antonelli et al. · Intensive Care Medicine · 2017 · 184 citations
Mario Tumbarello, Enrico Maria Trecarichi, Matteo Bassetti et al. · Antimicrobial Agents and Chemotherapy · 2011 · 157 citations
Veterinary Medicine, Clinical Sciences, Infectious Diseases +17